ClariTrial | Search Clinical Trials

Explore/Prostate Cancer

Status

Phase

8,595 results for “Prostate Cancer”

Page 1 of 573

Completed

The Effect of TENS on Pain, Complications and Comfort in Patients Who Had Prostate Biopsy With Transrectal Ultrasound

N/AProstate Cancer XXX

Transcuten Electriacal Nerve Stimulation

Cukurova University80 participants1 site · Turkey (Türkiye)Completes Mar 2022

Compare CT.gov Full analysis →

Not Yet Recruiting

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

N/AProstate Carcinoma

Behavioral InterventionBiospecimen CollectionElectronic Health Record Review+5 more

M.D. Anderson Cancer Center108 participants1 site · United StatesCompletes May 2030

Compare CT.gov Full analysis →

Active

Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy

N/ARecurrent Prostate Cancer

Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomyAndrogen deprivation therapy

Insel Gruppe AG, University Hospital Bern36 participants5 sites · SwitzerlandCompletes Nov 2027

Compare CT.gov Full analysis →

Not Yet Recruiting

Lu-177 PSMA Treatment in Cell Renal Carcinoma

Phase 3Metastatic Renal Cancer

Lu-177 PSMA-617

Ankara University20 participantsCompletes Feb 2028

Compare CT.gov Full analysis →

UNKNOWN

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

N/AProstate CancerProstate Disease

Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance

Northwell Health200 participants3 sites · United StatesCompletes Oct 2025

Compare CT.gov Full analysis →

Not Yet Recruiting

HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer

Phase 3Non-Muscle-Invasive Bladder Cancer

TURBTHIVECIntravesical Chemotherapy+1 more

Affiliated Cancer Hospital & Institute of Guangzhou Medical University320 participantsCompletes Mar 2026

Compare CT.gov Full analysis →

Completed

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

Phase 3Neoplasm, Prostate

Immediate Orchiectomy or depot LHRHDelayed Orchiectomy or depot LHRH

European Organisation for Research and Treatment of Cancer - EORTC985 participantsCompletes Jul 2004

Compare CT.gov Full analysis →

Active

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy

Phase 1Phase 2Prostatic Neoplasms

177Lu-PSMA-617

Peter MacCallum Cancer Centre, Australia20 participants1 site · AustraliaCompletes Dec 2022

Compare CT.gov Full analysis →

Recruiting

Safety and Efficacy of Two-step Radical Prostatectomy

N/AProstate Cancer

Two-step Radical Prostatectomy

Sun Yat-sen University30 participants1 site · ChinaCompletes Feb 2033

Compare CT.gov Full analysis →

Active

A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

Phase 2Metastatic Hormone-sensitive Prostate Cancer

Darolutamide (BAY1841788, Nubeqa)ADT

Bayer223 participants31 sites · United StatesCompletes May 2025

Compare CT.gov Full analysis →

Recruiting

N/AThyroid Nodule

thermal ablationthyroidectomy

Ming-an Yu500 participants1 site · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Improving Compliance With Medical Testing Guidelines

N/ABreast CancerCervical CancerProstate Cancer

Color-coded materialsAcademic detailingStandard support+1 more

Beth Israel Medical Center218 participants2 sites · United StatesCompletes Feb 2017

Compare CT.gov Full analysis →

Completed

Testosterone Replacement in Metabolic Syndrome and Inflammation

Phase 4HypogonadismMetabolic SyndromeObesity

TestosteronePlacebo

University of Roma La Sapienza82 participants2 sites · ItalyCompletes Oct 2014

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Phase 3Advanced Prostate Cancer

DKF-MA102

Dongkook Pharmaceutical Co., Ltd.154 participants1 site · South KoreaCompletes May 2025

Compare CT.gov Full analysis →

Withdrawn

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

N/AProstate Cancer

Physical Activity

Medical University of South Carolina01 site · United StatesCompletes Nov 2019

Compare CT.gov Full analysis →

1–15 of 8,595

Explore/Prostate Cancer

Status

Phase

8,595 results for “Prostate Cancer”

Page 1 of 573

Completed

The Effect of TENS on Pain, Complications and Comfort in Patients Who Had Prostate Biopsy With Transrectal Ultrasound

N/AProstate Cancer XXX

Transcuten Electriacal Nerve Stimulation

Cukurova University80 participants1 site · Turkey (Türkiye)Completes Mar 2022

Compare CT.gov Full analysis →

Not Yet Recruiting

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

N/AProstate Carcinoma

Behavioral InterventionBiospecimen CollectionElectronic Health Record Review+5 more

M.D. Anderson Cancer Center108 participants1 site · United StatesCompletes May 2030

Compare CT.gov Full analysis →

Active

Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy

N/ARecurrent Prostate Cancer

Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomyAndrogen deprivation therapy

Insel Gruppe AG, University Hospital Bern36 participants5 sites · SwitzerlandCompletes Nov 2027

Compare CT.gov Full analysis →

Not Yet Recruiting

Lu-177 PSMA Treatment in Cell Renal Carcinoma

Phase 3Metastatic Renal Cancer

Lu-177 PSMA-617

Ankara University20 participantsCompletes Feb 2028

Compare CT.gov Full analysis →

UNKNOWN

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

N/AProstate CancerProstate Disease

Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance

Northwell Health200 participants3 sites · United StatesCompletes Oct 2025

Compare CT.gov Full analysis →

Not Yet Recruiting

HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer

Phase 3Non-Muscle-Invasive Bladder Cancer

TURBTHIVECIntravesical Chemotherapy+1 more

Affiliated Cancer Hospital & Institute of Guangzhou Medical University320 participantsCompletes Mar 2026

Compare CT.gov Full analysis →

Completed

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

Phase 3Neoplasm, Prostate

Immediate Orchiectomy or depot LHRHDelayed Orchiectomy or depot LHRH

European Organisation for Research and Treatment of Cancer - EORTC985 participantsCompletes Jul 2004

Compare CT.gov Full analysis →

Active

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy

Phase 1Phase 2Prostatic Neoplasms

177Lu-PSMA-617

Peter MacCallum Cancer Centre, Australia20 participants1 site · AustraliaCompletes Dec 2022

Compare CT.gov Full analysis →

Recruiting

Safety and Efficacy of Two-step Radical Prostatectomy

N/AProstate Cancer

Two-step Radical Prostatectomy

Sun Yat-sen University30 participants1 site · ChinaCompletes Feb 2033

Compare CT.gov Full analysis →

Active

Phase 2Metastatic Hormone-sensitive Prostate Cancer

Darolutamide (BAY1841788, Nubeqa)ADT

Bayer223 participants31 sites · United StatesCompletes May 2025

Compare CT.gov Full analysis →

Recruiting

N/AThyroid Nodule

thermal ablationthyroidectomy

Ming-an Yu500 participants1 site · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Improving Compliance With Medical Testing Guidelines

N/ABreast CancerCervical CancerProstate Cancer

Color-coded materialsAcademic detailingStandard support+1 more

Beth Israel Medical Center218 participants2 sites · United StatesCompletes Feb 2017

Compare CT.gov Full analysis →

Completed

Testosterone Replacement in Metabolic Syndrome and Inflammation

Phase 4HypogonadismMetabolic SyndromeObesity

TestosteronePlacebo

University of Roma La Sapienza82 participants2 sites · ItalyCompletes Oct 2014

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Phase 3Advanced Prostate Cancer

DKF-MA102

Dongkook Pharmaceutical Co., Ltd.154 participants1 site · South KoreaCompletes May 2025

Compare CT.gov Full analysis →

Withdrawn

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

N/AProstate Cancer

Physical Activity

Medical University of South Carolina01 site · United StatesCompletes Nov 2019

Compare CT.gov Full analysis →

1–15 of 8,595